• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

    21.61 -1.31 (-5.72%)
    Streaming Delayed Price Updated: 12:55 PM EDT, Apr 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Amphastar Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today
    What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 5.7% in the afternoon session after Jefferies downgraded the stoc... 
    Via StockStory
    Topics Economy
    News headline image
    Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings?
    Over the last six months, Amphastar Pharmaceuticals’s shares have sunk to $22.73, producing a disappointing 6.3% loss - a stark contrast to the S&P 500’s 5.8... 
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
    What Happened? A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy ... 
    Via StockStory
    Topics Economy
    News headline image
    1 Healthcare Stock to Target This Week and 2 We Avoid
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have seen decent returns lat... 
    Via StockStory
    Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Plummets After Q4 Earnings Miss Estimates ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
    Via ACCESS Newswire
    News headline image
    1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm
    Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
    Via StockStory
    News headline image
    3 of Wall Street’s Favorite Stocks We Think Twice About
    Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
    Via StockStory
    News headline image
    NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
    What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ... 
    Via StockStory
    Topics Economy Stocks
    News headline image
    AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH)
    Looking back on generic pharmaceuticals stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Amphastar Pharmaceuticals (NASDAQ... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today
    Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 15.8% in the afternoon session after the company reported fourth-quarter 2025 financial results that fell short of Wall... 
    Via StockStory
    Topics Economy
    News headline image
    Amphastar (AMPH) Q4 2025 Earnings Call Transcript ↗
    Amphastar (AMPH) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings Supply Chain
    News headline image
    Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7%
    Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 1.8% year on year to $183.1 million. Its non-GAAP profit... 
    Via StockStory
    Topics Artificial Intelligence Supply Chain
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect
    Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) will be reporting earnings tomorrow after market hours. Here’s what to expect. 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Amphastar Announces FDA Approval for Ipratropium Bromide HFA
    Via ACCESS Newswire
    News headline image
    Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
    Via ACCESS Newswire
    News headline image
    1 Value Stock on Our Watchlist and 2 We Turn Down
    The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
    Via StockStory
    Topics Retirement
    News headline image
    Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know
    A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a... 
    Via StockStory
    Topics Economy
    News headline image
    3 Cash-Producing Stocks We Keep Off Our Radar
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
    Via StockStory
    News headline image
    3 Stocks Under $50 with Warning Signs
    Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving
    Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 5.3% in the afternoon session after a Bank of America analyst lowered the firm's price target on the shares and reports... 
    Via StockStory
    News headline image
    2 Reasons to Avoid AMPH and 1 Stock to Buy Instead
    Amphastar Pharmaceuticals has had an impressive run over the past six months as its shares have beaten the S&P 500 by 19.5%. The stock now trades at $27.76, marking a 31% gain. This was partly due to... 
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    1 Profitable Stock Worth Your Attention and 2 Facing Headwinds
    While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
    Via StockStory
    News headline image
    Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
    Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 5.8% in the afternoon session after the company announced it had entered into an exclusive license agreement with Nanjing... 
    Via StockStory
    News headline image
    Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
    Via ACCESS Newswire
    News headline image
    3 Low-Volatility Stocks We Find Risky
    Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
    Via StockStory
    News headline image
    Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
    Via ACCESS Newswire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.